HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kaoru Ogawa Selected Research

SC 791

5/2014Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kaoru Ogawa Research Topics

Disease

33Hearing Loss (Hearing Impairment)
11/2021 - 05/2003
27Neoplasms (Cancer)
07/2021 - 10/2005
23Tinnitus
06/2022 - 09/2002
17Sensorineural Hearing Loss
06/2022 - 09/2002
9Neoplasm Metastasis (Metastasis)
01/2022 - 03/2007
8Head and Neck Neoplasms (Head and Neck Cancer)
11/2021 - 01/2007
8Squamous Cell Carcinoma of Head and Neck
07/2021 - 11/2003
7Carcinoma (Carcinomatosis)
09/2021 - 05/2003
7Dizziness (Lightheadedness)
10/2014 - 12/2005
6Hypopharyngeal Neoplasms
10/2020 - 06/2006
5Vertigo (Positional Vertigo)
11/2021 - 01/2008
5Deafness (Deaf Mutism)
01/2021 - 01/2016
5Lymphatic Metastasis
01/2018 - 05/2003
5Noise-Induced Hearing Loss (Acoustic Trauma)
05/2015 - 05/2007
5Meniere Disease (Menieres Disease)
02/2014 - 01/2008
4Paralysis (Palsy)
01/2022 - 07/2007
4Wounds and Injuries (Trauma)
08/2021 - 06/2009
4Hemorrhage
05/2021 - 03/2009
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018 - 07/2007
4Infections
01/2018 - 11/2005
4Granuloma
01/2015 - 03/2007
3Tympanic Membrane Perforation
12/2021 - 06/2010
3Otitis Media
08/2021 - 06/2010
3Lymphoma (Lymphomas)
05/2021 - 03/2015
3Fistula
09/2020 - 06/2006
3Pendred syndrome
05/2020 - 01/2017
3Necrosis
01/2020 - 01/2011
3Cysts
01/2015 - 11/2009
3Mitochondrial Diseases (Mitochondrial Disease)
01/2014 - 07/2005
3Laryngeal Neoplasms (Laryngeal Cancer)
04/2009 - 06/2006
3Recurrent Laryngeal Nerve Injuries
07/2007 - 02/2003
3Atopic Dermatitis (Atopic Eczema)
10/2005 - 06/2004
2Facial Paralysis (Facial Palsy)
10/2022 - 10/2016
2Pathologic Constriction (Stenosis)
03/2021 - 06/2006
2Neurodegenerative Diseases (Neurodegenerative Disease)
05/2020 - 05/2015
2Neurofibromatosis 2 (Neurofibromatosis Type II)
01/2020 - 12/2019
2Neurilemmoma (Schwannoma)
12/2019 - 12/2009
2Allergic Rhinitis
03/2019 - 09/2012
2Seasonal Allergic Rhinitis (Hay Fever)
03/2019 - 01/2013
2Hypothyroidism
01/2019 - 01/2007
2Recurrent respiratory papillomatosis
01/2017 - 04/2010
2Labyrinth Diseases
01/2017 - 07/2002

Drug/Important Bio-Agent (IBA)

7SteroidsIBA
10/2020 - 01/2009
6Anti-Bacterial Agents (Antibiotics)IBA
08/2021 - 07/2009
5Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
11/2021 - 01/2008
5Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2004
53-nitropropionic acidIBA
01/2014 - 07/2005
4CytokinesIBA
04/2010 - 12/2004
3Pharmaceutical PreparationsIBA
06/2022 - 05/2003
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2021 - 05/2014
3Docetaxel (Taxotere)FDA Link
07/2021 - 03/2007
3ConnexinsIBA
01/2021 - 07/2007
3Cadherins (E-Cadherin)IBA
01/2020 - 02/2012
3SolutionsIBA
01/2020 - 09/2012
3Antidepressive Agents (Antidepressants)IBA
01/2018 - 01/2008
3Messenger RNA (mRNA)IBA
05/2014 - 12/2004
3Interleukin-6 (Interleukin 6)IBA
01/2014 - 04/2010
3Brain-Derived Neurotrophic Factor (BDNF)IBA
02/2012 - 03/2006
3Free RadicalsIBA
06/2009 - 05/2007
3Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
07/2007 - 02/2003
2Antiviral Agents (Antivirals)IBA
10/2022 - 10/2016
2C-Reactive ProteinIBA
01/2022 - 03/2015
2Celecoxib (Celebrex)FDA Link
07/2021 - 05/2014
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
07/2021 - 05/2014
2Sirolimus (Rapamycin)FDA Link
05/2020 - 06/2019
2VaccinesIBA
01/2020 - 12/2019
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2020 - 12/2019
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2019 - 01/2018
2Androgen Receptors (Androgen Receptor)IBA
01/2018 - 09/2013
2Adrenal Cortex Hormones (Corticosteroids)IBA
08/2017 - 10/2016
2Biological ProductsIBA
08/2017 - 06/2008
2Mitochondrial DNA (mtDNA)IBA
01/2017 - 01/2017
2ThyroglobulinFDA Link
05/2016 - 12/2011
2Neuroprotective AgentsIBA
05/2015 - 05/2008
2Adenosine Triphosphate (ATP)IBA
02/2015 - 04/2010

Therapy/Procedure

39Therapeutics
10/2022 - 07/2002
12Drug Therapy (Chemotherapy)
01/2022 - 11/2003
10Hearing Aids (Hearing Aid)
06/2022 - 01/2013
9Radiotherapy
01/2022 - 01/2007
6Aftercare (After-Treatment)
06/2022 - 12/2005
4Operative Surgical Procedures
10/2022 - 01/2016
4Tympanoplasty
08/2021 - 10/2017
4Lasers (Laser)
03/2019 - 04/2010
4Autogenic Training
01/2018 - 01/2008
3Cochlear Implantation
10/2022 - 01/2016
3Injections
10/2020 - 01/2012
3Chemoradiotherapy
12/2017 - 11/2003
3Laryngectomy
04/2009 - 06/2006
2Conservative Treatment
01/2022 - 01/2019
2Oral Administration
05/2020 - 07/2007
2Cochlear Implants (Cochlear Implant)
02/2020 - 01/2017
2Debridement
01/2020 - 01/2015
2Solid-State Lasers
03/2019 - 09/2012
2Semiconductor Lasers
03/2019 - 09/2012
2Neoadjuvant Therapy
01/2018 - 11/2003
2Surgical Instruments (Clip)
06/2017 - 06/2016
2Laser Therapy (Surgery, Laser)
01/2017 - 01/2016
2Electrocoagulation (Electrocautery)
06/2016 - 11/2009
2Glossectomy
10/2015 - 02/2012
2Decompression
03/2015 - 08/2012